LONG-TERM SURVIVAL IN ACUTE MYELOID-LEUKEMIA - THE-EASTERN-COOPERATIVE-ONCOLOGY-GROUP (ECOG) EXPERIENCE

被引:38
|
作者
BENNETT, JM
ANDERSEN, JW
CASSILETH, PA
机构
[1] UNIV ROCHESTER,MED CTR,ROCHESTER,NY 14642
[2] HARVARD UNIV,SCH PUBL HLTH,DANA FARBER CANC INST,DIV BIOSTAT & EPIDEMIOL,BOSTON,MA 02115
[3] UNIV PENN,CTR CANC,PHILADELPHIA,PA 19104
[4] HOSP UNIV PENN,DEPT MED,PHILADELPHIA,PA 19104
关键词
PROMYELOCYTIC LEUKEMIA; CURABILITY OF LEUKEMIA;
D O I
10.1016/0145-2126(91)90124-C
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A retrospective analysis of two ECOG adult AML trials conducted from 1976 to 1983 was carried out focusing on long term disease-free survival. This report summarizes the data on 545 patients with a minimum follow up of 7 1/2 years. The complete remission rate was 57% with an estimated cure rate of 12%. Of several prognostic variables examined only FAB type M3 (promyelocytic leukemia) was statistically significant (estimated cure rate of 33% vs 9% for other FAB subtypes).
引用
收藏
页码:223 / 227
页数:5
相关论文
共 50 条
  • [31] FERTILITY IN LONG-TERM SURVIVORS OF ACUTE MYELOID LEUKEMIA
    Branvall, K.
    Derolf, A.
    Johansson, E.
    Hultcrantz, M.
    Bergmark, K.
    Bjorkholm, M.
    HAEMATOLOGICA, 2012, 97 : 30 - 31
  • [32] AUTOLOGOUS BMT FOR ACUTE MYELOID-LEUKEMIA - CLINICAL USE OF MARROW GROWN IN LONG-TERM CULTURE SYSTEM
    MORGENSTERN, GR
    CHANG, J
    DEXTER, TM
    SCARFFE, JH
    COUTINHO, L
    TESTA, NG
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1986, : 219 - 219
  • [33] CARBOPLATIN INFUSION IN RELAPSED AND REFRACTORY ACUTE MYELOID-LEUKEMIA - A SOUTHWEST-ONCOLOGY-GROUP TRIAL
    WELBORN, JL
    KOPECKY, KJ
    MEYERS, FJ
    VEITH, R
    SHURAFA, M
    DOROSHOW, JH
    BALCERZAK, SP
    APPELBAUM, FR
    LEUKEMIA, 1995, 9 (07) : 1126 - 1129
  • [34] Mitotzantrone, etoposide and cytosine arabinoside (MEC) plus cyclosporine (CSP) in patients with relapsed or refractory acute myeloid leukemia (AML): An eastern cooperative oncology group (ECOG) pilot study.
    Tallman, MS
    Lee, S
    Sikic, B
    Paletta, E
    Bennett, JM
    Rowe, JM
    Wiernik, PH
    BLOOD, 1996, 88 (10) : 851 - 851
  • [35] Long-term follow-up of Cancer and Leukemia Group B studies in acute myeloid leukemia
    Schiffer, CA
    Dodge, R
    Larson, RA
    CANCER, 1997, 80 (11) : 2210 - 2214
  • [36] REPRODUCIBILITY OF THE MORPHOLOGICAL DIAGNOSTIC-CRITERIA FOR ACUTE MYELOID-LEUKEMIA - THE GIMEMA GROUP EXPERIENCE
    CASTOLDI, GL
    LISO, V
    FENU, S
    VEGNA, ML
    MANDELLI, F
    ANNALS OF HEMATOLOGY, 1993, 66 (04) : 171 - 174
  • [37] Simple acute phase protein score to predict long-term survival in patients with acute myeloid leukemia
    Heini, Alexander D.
    Hugo, Rebecca
    Berger, Martin D.
    Novak, Urban
    Bacher, Ulrike
    Pabst, Thomas
    HEMATOLOGICAL ONCOLOGY, 2020, 38 (01) : 74 - 81
  • [38] A simple acute phase protein score to predict long-term survival in patients with acute myeloid leukemia
    Hein, Alexander D.
    Hugo, Rebecca
    Berger, Martin D.
    Novak, Urban
    Bacher, Ulrike
    Pabst, Thomas
    SWISS MEDICAL WEEKLY, 2019, 149 : 4S - 4S
  • [39] A simple acute phase protein score to predict long-term survival in patients with acute myeloid leukemia
    Heini, A.
    Hugo, R.
    Berger, M. D.
    Novak, U.
    Bacher, U.
    Pabst, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 85 - 85
  • [40] Uncommon long-term survival in a patient with chronic myeloid leukemia
    Stagno, Fabio
    Vigneri, Paolo
    Del Fabro, Vittorio
    Stella, Stefania
    Berretta, Salvatore
    Massimino, Michele
    Tirro, Elena
    Messina, Angelo
    Di Raimondo, Francesco
    ACTA ONCOLOGICA, 2009, 48 (08) : 1215 - 1216